Literature DB >> 19008854

Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1.

Fulvia Terenzi1, Paramananda Saikia, Ganes C Sen.   

Abstract

Type I interferon (IFN) inhibits, by an unknown mechanism, the replication of human papillomaviruses (HPV), which are major human pathogens, Here, we present evidence that P56 (a protein), the expression of which is strongly induced by IFN, double-stranded RNA and viruses, mediates the anti-HPV effect of IFN. Ectopic expression of P56 inhibited HPV DNA replication and its ablation in IFN-treated cells alleviated the inhibitory effect of IFN on HPV DNA replication. Protein-protein interaction and mutational analyses established that the antiviral effect of P56 was mediated by its direct interaction with the DNA replication origin-binding protein E1 of several strains of HPV, through the tetratricopeptide repeat 2 in the N-terminal region of P56 and the C-terminal region of E1. In vivo, the interaction with P56, a cytoplasmic protein, caused translocation of E1 from the nucleus to the cytoplasm. In vitro, recombinant P56, or a small fragment derived from it, inhibited the DNA helicase activity of E1 and E1-mediated HPV DNA replication. These observations delineate the molecular mechanism of IFN's antiviral action against HPV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008854      PMCID: PMC2609736          DOI: 10.1038/emboj.2008.241

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.

Authors:  Eric A Abbate; James M Berger; Michael R Botchan
Journal:  Genes Dev       Date:  2004-08-02       Impact factor: 11.361

2.  Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus.

Authors:  J Guo; G C Sen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

4.  Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes.

Authors:  Nathalie Grandvaux; Marc J Servant; Benjamin tenOever; Ganes C Sen; Siddarth Balachandran; Glen N Barber; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  A new pathway of translational regulation mediated by eukaryotic initiation factor 3.

Authors:  J Guo; D J Hui; W C Merrick; G C Sen
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 6.  Current treatment strategies for chronic hepatitis B and C.

Authors:  O S Lin; E B Keeffe
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

7.  Simian virus 40 DNA replication in vitro.

Authors:  J J Li; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.

Authors:  S C Dollard; J L Wilson; L M Demeter; W Bonnez; R C Reichman; T R Broker; L T Chow
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

Review 9.  Novel functions of proteins encoded by viral stress-inducible genes.

Authors:  Saumendra N Sarkar; Ganes C Sen
Journal:  Pharmacol Ther       Date:  2004-09       Impact factor: 12.310

10.  Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells.

Authors:  L P Turek; J C Byrne; D R Lowy; I Dvoretzky; R M Friedman; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  83 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Authors:  Olivia Perwitasari; Hyelim Cho; Michael S Diamond; Michael Gale
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

Review 4.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

5.  Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.

Authors:  Amelia K Pinto; Graham D Williams; Kristy J Szretter; James P White; José Luiz Proença-Módena; Gai Liu; Judith Olejnik; James D Brien; Hideki Ebihara; Elke Mühlberger; Gaya Amarasinghe; Michael S Diamond; Adrianus C M Boon
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

6.  Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.

Authors:  Lanlan Wei; Anastacia M Griego; Ming Chu; Michelle A Ozbun
Journal:  Carcinogenesis       Date:  2014-07-26       Impact factor: 4.944

7.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).

Authors:  Hasan H Danish; Sharad Goyal; Neil K Taunk; Hao Wu; Meena S Moran; Bruce G Haffty
Journal:  Breast J       Date:  2013-03-26       Impact factor: 2.431

Review 9.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

10.  Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45.

Authors:  Fan Xiu Zhu; Narayanan Sathish; Yan Yuan
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.